Modelling the potential clinical and economic impact of universal immunisation with nirsevimab versus standard of practice for protecting all neonates and infants in their first respiratory syncytial virus season in Spain

对西班牙首次呼吸道合胞病毒季节中所有新生儿和婴儿进行全面免疫接种的潜在临床和经济影响进行建模，并与保护所有新生儿和婴儿的标准做法进行比较